Koyota S, Ikeda Y, Miyagawa S, Ihara H, Koma M, Honke K, Shirakura R, Taniguchi N
Department of Biochemistry, Osaka University Medical School, Suita 565-0871, Osaka, Japan.
J Biol Chem. 2001 Aug 31;276(35):32867-74. doi: 10.1074/jbc.M102371200. Epub 2001 Jul 6.
The down-regulation of the alpha-Gal epitope (Galalpha1,3Galbeta-R) in swine tissues would be highly desirable, in terms of preventing hyperacute rejection in pig-to-human xenotransplantation. In an earlier study, we reported that the introduction of the beta1,4-N-acetylglucosaminyltransferase (GnT) III gene into swine endothelial cells resulted in a substantial reduction in the expression of the alpha-Gal epitope. In this study, we report on the mechanism for this down-regulation of the alpha-Gal epitope by means of structural and kinetic analyses. The structural analyses revealed that the amount of N-linked oligosaccharides bearing the alpha-Gal epitopes in the GnT-III-transfected cells was less than 10% that in parental cells, due to the alteration of the terminal structures as well as a decrease in branch formation. In addition, it appeared that the addition of a bisecting GlcNAc, which is catalyzed by GnT-III, leads to a more efficient sialylation rather than alpha-galactosylation. In vitro kinetic analyses showed that the bisecting GlcNAc has an inhibitory effect on alpha-galactosylation, but does not significantly affect the sialylation. These results suggest that the bisecting GlcNAc in the core is capable of modifying the biosynthesis of the terminal structures via its differential effects on the capping glycosyltransferase reactions. The findings may contribute to the development of a novel strategy to eliminate carbohydrate xenoantigens.
就预防猪到人的异种移植中的超急性排斥反应而言,猪组织中α-半乳糖表位(Galα1,3Galβ-R)的下调是非常可取的。在早期研究中,我们报道将β1,4-N-乙酰葡糖胺基转移酶(GnT)III基因导入猪内皮细胞可导致α-半乳糖表位的表达大幅降低。在本研究中,我们通过结构和动力学分析报告了α-半乳糖表位下调的机制。结构分析表明,由于末端结构的改变以及分支形成的减少,GnT-III转染细胞中带有α-半乳糖表位的N-连接寡糖的量不到亲本细胞的10%。此外,似乎由GnT-III催化添加的平分型GlcNAc导致更有效的唾液酸化而非α-半乳糖基化。体外动力学分析表明,平分型GlcNAc对α-半乳糖基化有抑制作用,但对唾液酸化没有显著影响。这些结果表明,核心中的平分型GlcNAc能够通过其对封端糖基转移酶反应的不同影响来改变末端结构的生物合成。这些发现可能有助于开发一种消除碳水化合物异种抗原的新策略。